Search Results - "Clinical nuclear medicine"

Feasibility and Therapeutic Potential of 177Lu–Fibroblast Activation Protein Inhibitor–46 for Patients With Relapsed or Refractory Cancers: A Preliminary Study by Assadi, Majid, Rekabpour, Seyed Javad, Jafari, Esmail, Divband, GhasemAli, Nikkholgh, Babak, Amini, Hamidreza, Kamali, Hassan, Ebrahimi, Sakineh, Shakibazad, Nader, Jokar, Narges, Nabipour, Iraj, Ahmadzadehfar, Hojjat

“…Introduction Fibroblast activation protein (FAP) is a member of the serine protease family and has a high expression in the stroma of approximately 90% of…”
Get full text

A Machine-Learning Approach Using PET-Based Radiomics to Predict the Histological Subtypes of Lung Cancer by Hyun, Seung Hyup, Ahn, Mi Sun, Koh, Young Wha, Lee, Su Jin

“…PURPOSEWe sought to distinguish lung adenocarcinoma (ADC) from squamous cell carcinoma using a machine-learning algorithm with PET-based radiomic features…”
Get full text

Fibroblast Activation Protein Inhibitor PET/CT: A Promising Molecular Imaging Tool by Sharma, Punit, Singh, Shashank Shekhar, Gayana, Shankaramurthy

“…Fibroblast activation protein (FAP) is a cell membrane-bound serine peptidase, overexpressed in cancer-associated fibroblasts and activated fibroblasts at…”
Get full text

Brain PET in the Diagnosis of Alzheimer’s Disease by Marcus, Charles, Mena, Esther, Subramaniam, Rathan M

“…OBJECTIVESThe aim of this article was to review the current role of brain PET in the diagnosis of Alzheimer dementia. The characteristic patterns of glucose…”
Get full text

A Prospective Head-to-Head Comparison of 18F-Fluciclovine With 68Ga-PSMA-11 in Biochemical Recurrence of Prostate Cancer in PET/CT by Pernthaler, Birgit, Kulnik, Roman, Gstettner, Christian, Salamon, Spela, Aigner, Reingard M, Kvaternik, Herbert

“…PURPOSEOne of the major challenges for all imaging modalities is accurate detection of prostate cancer (PCa) recurrence. Beyond the established Ga-PSMA, a…”
Get full text

Predicting Response to Immunotherapy by Evaluating Tumors, Lymphoid Cell-Rich Organs, and Immune-Related Adverse Events Using FDG-PET/CT by Nobashi, Tomomi, Baratto, Lucia, Reddy, Sunil A, Srinivas, Sandhya, Toriihara, Akira, Hatami, Negin, Yohannan, Thomas K, Mittra, Erik

“…PURPOSETo investigate whether the evaluation of tumors, lymphoid cell-rich organs, and immune-related adverse events (IRAE) with F-FDG PET/CT can predict the…”
Get full text

Decentralized Distributed Multi-institutional PET Image Segmentation Using a Federated Deep Learning Framework by Shiri, Isaac, Vafaei Sadr, Alireza, Amini, Mehdi, Salimi, Yazdan, Sanaat, Amirhossein, Akhavanallaf, Azadeh, Razeghi, Behrooz, Ferdowsi, Sohrab, Saberi, Abdollah, Arabi, Hossein, Becker, Minerva, Voloshynovskiy, Slava, Gündüz, Deniz, Rahmim, Arman, Zaidi, Habib

“…The generalizability and trustworthiness of deep learning (DL)-based algorithms depend on the size and heterogeneity of training datasets. However, because of…”
Get full text

Therapeutic Responses and Survival Effects of 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castrate-Resistant Prostate Cancer: A Meta-analysis by Kim, Yong Joong, Kim, Yong-il

“…PURPOSEWe performed a meta-analysis on the therapeutic effects of prostate-specific membrane antigen (PSMA)–617 labeled with lutetium-177 (Lu-PSMA-617) in…”
Get full text

Theranostic Approach in Breast Cancer: A Treasured Tailor for Future Oncology by Jokar, Narges, Velikyan, Irina, Ahmadzadehfar, Hojjat, Rekabpour, Seyed Javad, Jafari, Esmail, Ting, Hong Hoi, Biersack, Hans-Jürgen, Assadi, Majid

“…Abstract Breast cancer is the most frequent invasive malignancy and the second major cause of cancer death in female subjects mostly due to the considerable…”
Get full text

Choline PET or PET/CT and Biochemical Relapse of Prostate Cancer: A Systematic Review and Meta-Analysis by Evangelista, Laura, Zattoni, Fabio, Guttilla, Andrea, Saladini, Giorgio, Zattoni, Filiberto, Colletti, Patrick M, Rubello, Domenico

“…AIMThe increase of prostate-specific antigen (PSA) after radical retropubic prostatectomy (RP) or external beam radiotherapy (EBRT) is the most sensitive tool…”
Get full text

Impact of 18F-FDG PET, PET/CT, and PET/MRI on Staging and Management as an Initial Staging Modality in Breast Cancer: A Systematic Review and Meta-analysis by Han, Sangwon, Choi, Joon Young

“…We performed a systematic review and meta-analysis to evaluate the impact of 18F-FDG PET, PET/CT, and PET/MRI on staging and management during the initial…”
Get full text

Comparative Effectiveness of Ultrasonography, 99mTc-Sestamibi, and 18F-Fluorocholine PET/CT in Detecting Parathyroid Adenomas in Patients With Primary Hyperparathyroidism by Thanseer, Ntk, Bhadada, Sanjay Kumar, Sood, Ashwani, Mittal, Bhagwant Rai, Behera, Arunanshu, Gorla, Arun Kumar Reddy, Kalathoorakathu, Renjith R, Singh, Priyanka, Dahiya, Divya, Saikia, Uma Nahar, Rao, Sudhaker D

“…Accurate preoperative localization of parathyroid lesion(s) is crucial for successful surgical management of primary hyperparathyroidism (PHPT). This study was…”
Get full text

89Zr-Trastuzumab PET/CT for Detection of Human Epidermal Growth Factor Receptor 2–Positive Metastases in Patients With Human Epidermal Growth Factor Receptor 2–Negative Primary Breast Cancer by Ulaner, Gary A, Hyman, David M, Lyashchenko, Serge K, Lewis, Jason S, Carrasquillo, Jorge A

“…PURPOSEThe aim of this study was to determine if imaging with Zr-trastuzumab, a human epidermal growth factor receptor 2 (HER2)–targeting PET tracer, can…”
Get full text

Fully Automated Gross Tumor Volume Delineation From PET in Head and Neck Cancer Using Deep Learning Algorithms by Shiri, Isaac, Arabi, Hossein, Sanaat, Amirhossein, Jenabi, Elnaz, Becker, Minerva, Zaidi, Habib

“…Purpose The availability of automated, accurate, and robust gross tumor volume (GTV) segmentation algorithms is critical for the management of head and neck…”
Get full text

Impact of 68Ga-FAPI-04 PET/CT on Staging and Therapeutic Management in Patients With Digestive System Tumors by Kosmala, Aleksander, Serfling, Sebastian E., Schlötelburg, Wiebke, Lindner, Thomas, Michalski, Kerstin, Schirbel, Andreas, Higuchi, Takahiro, Hartrampf, Philipp E., Buck, Andreas K., Weich, Alexander, Werner, Rudolf A.

“…Purpose We aimed to determine the impact of fibroblast activation protein inhibitor (FAPI)–directed molecular imaging on staging and therapeutic management in…”
Get full text

COVID-19 mRNA Vaccination–Induced Lymphadenopathy Mimics Lymphoma Progression on FDG PET/CT by Xu, Guofan, Lu, Yang

“…We present here a 72-year-old man with mantle cell lymphoma who has completed chemotherapy and achieved complete metabolic response to the therapy 10 months…”
Get full text

The Challenge of Staging Breast Cancer With PET/CT in the Era of COVID Vaccination by Brown, Adam Harry, Shah, Sweni, Groves, Ashley M., Wan, Simon, Malhotra, Anmol

“…We report a case series of biopsy-proven reactive axillary lymph nodes, which were avid on FDG PET/CT in breast cancer patients post COVID-19 vaccination. With…”
Get full text

Clinical Application of 18F-AlF-NOTA-Octreotide PET/CT in Combination With 18F-FDG PET/CT for Imaging Neuroendocrine Neoplasms by Long, Tingting, Yang, Nengan, Zhou, Ming, Chen, Dengming, Li, Yulai, Li, Jian, Tang, Yongxiang, Liu, Zhaoqian, Li, Zibo, Hu, Shuo

“…OBJECTIVESThe study is to evaluate biodistribution, dosimetry, safety, and clinical usefulness of F-AlF-NOTA-octreotide (F-OC) PET/CT in combination with F-FDG…”
Get full text

Two Tumors, One Target: Preliminary Experience With 90Y-FAPI Therapy in a Patient With Metastasized Breast and Colorectal Cancer by Rathke, Hendrik, Fuxius, Stefan, Giesel, Frederik L., Lindner, Thomas, Debus, Jürgen, Haberkorn, Uwe, Kratochwil, Clemens

“…Abstract We report a patient with breast cancer (BC) diagnosed in 2009 with metachronous lymph node, liver, and bone metastases. In 2017, colorectal cancer…”
Get full text

Peptide Receptor Radionuclide Therapy Combined With Chemotherapy in Patients With Neuroendocrine Tumors by Yordanova, Anna, Ahrens, Harriet, Feldmann, Georg, Brossart, Peter, Gaertner, Florian C, Fottner, Christian, Weber, Matthias M, Ahmadzadehfar, Hojjat, Schreckenberger, Mathias, Miederer, Matthias, Essler, Markus

“…PURPOSECombinations of therapies may enhance therapeutic effects without significantly increasing the incidence of adverse events. However, there are few data…”
Get full text